GLUE
Monte Rosa Therapeutics, Inc. Common Stock
stockNASDAQ
At CloseNov 13, 2026 3:59:57 PM EST
9.37USD+0.644%(+0.06)1,119,299
Pre-marketNov 13, 2026 9:27:30 AM EST
9.38USD+0.752%(+0.07)
After-hoursNov 13, 2026 4:00:30 PM EST
9.37USD0.000%(0.00)
GLUE Financials
In Q3 FY 2026 (ended ), Monte Rosa Therapeutics, Inc. Common Stock (GLUE) reported revenue of $54.37M, net income of $3.06M, operating cash flow of −$40.98M, and assets of $697.73M (filed ).
Loading financial statements…